Complement-mediated lesion of sympathetic ganglia in vitro with acetylcholinesterase antibodies

Journal of Neuroimmunology

Volumn 97, Issue 1-2, 1999, Pages 86-93

  Tang, Hui ^a   Miller, Steven M ^a   Ermilov, Leonid G ^a   Lennon, Vanda A ^a   Brimijoin, Stephen ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acetylcholinesterase; Ganglia; Rat

Indexed keywords

ACETYLCHOLINESTERASE; ANTIBODY; CHOLINE ACETYLTRANSFERASE; COMPLEMENT; SYNAPTOPHYSIN;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; EXCITATORY POSTSYNAPTIC POTENTIAL; MALE; MOUSE; NERVE CELL CULTURE; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RAT; SUPERIOR CERVICAL GANGLION; SYMPATHETIC GANGLION;

ACETYLCHOLINESTERASE; ANIMALS; AUTOANTIBODIES; BLOOD PROTEINS; CHOLINE O-ACETYLTRANSFERASE; COMPLEMENT SYSTEM PROTEINS; EXCITATORY POSTSYNAPTIC POTENTIALS; HUMANS; LEUKOCYTES; MALE; MEMBRANE POTENTIALS; ORGAN CULTURE TECHNIQUES; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SUPERIOR CERVICAL GANGLION; SYNAPTIC TRANSMISSION;

EID: 0032936964     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00060-0     Document Type: Article

References (38)

1. Agoropoulou C., Piddlesden S.J., Lachmann P.J., Wing M.G. Neuronal protection of oligodendrocytes from antibody-independent complement lysis. NeuroReport. 9:1998;927-932.
2. Ballow M., Cochrane C.G. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J. Immunol. 103:1969;944-952.
3. Brimijoin S., Lennon V.A. Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. Proc. Natl. Acad. Sci. USA. 87:1990;9630-9634.
4. Brimijoin S., Balm M., Hammond P., Lennon V.A. Selective complexing of acetylcholinesterase in brain by intravenously administered monoclonal antibody. J. Neurochem. 54:1990;236-241.
5. Brimijoin S., Moser V., Hammond P., Oka N., Lennon V.A. Death of intermediolateral spinal cord neurons follows selective, complement-mediated destruction of preganglionic sympathetic terminals by acetylcholinesterase antibodies. Neuroscience. 54:1993;201-223.
6. Brimijoin, S., Hammond, P., Rakonczay, Z., 1995. Mechanism and implications of selective neural lesions by acetylcholinesterase antibodies in the central and peripheral nervous systems. In: Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P. (Eds.), Enzymes of the Cholinesterase Family. Plenum, New York, pp. 247-251.
7. Bruck W., Friede R.L. The role of complement in myelin phagocytosis during PNS Wallerian degeneration. J. Neurol. Sci. 103:1991;182-187.
8. Bruck W., Bruck Y., Friede R.L. TNF-alpha suppresses CR3-mediated myelin removal by macrophages. J. Neuroimmunol. 38:1992;9-18.
9. Causing C.G., Gloster A., Aloyz R., Bamji S.X., Chang E., Fawcett J., Kuchel G., Miller F.D. Synaptic innervation density is regulated by neuron-derived BDNF. Neuron. 18:1997;257-267.
10. Compston D.A.S., Morgan B.P., Campbell A.K., Wilkins P., Cole G., Thomas N.D., Jasani B. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol. Appl. Neurobiol. 15:1989;307-316.
11. Engel A.G., Lambert E.H., Howard F.M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clinic Proc. 52(5):1977;267-280.
12. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24:1975;407-409.
13. Frank, M.M., Fries, L.F., 1989. Complement. In: Paul, W.E. (Ed.), Fundamental Immunology. Raven Press, New York, pp. 679-701.
14. Fukuoka Y., Yasui A., Okada N., Okada H. Molecular cloning of murine decay accelerating factor by immunoscreening. Int. Immunol. 8:1996;379-385.
15. Gabella, G., 1976. Structure of the Autonomic Nervous System. Chapman and Hall, London, pp. 36-40.
16. Groves M.J., Christopherson T., Giometto B., Scaravilli F. Axotomy-induced apoptosis in adult rat primary sensory neurons. J. Neurocytol. 26:1997;615-624.
17. Jander S., Pohl J., Gillen C., Stoll G. Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system. J. Neurosci. Res. 43:1996;254-259.
18. Johnson E.M., Chang J.Y., Koike T., Martin D.P. Why do neurons die when deprived of trophic factor? Neurobiol. Aging. 10:1989;549-552.
19. Koelle G.B., Friedenwald J.S. A histochemical method for localizing cholinesterase activity. Proc. Soc. Exp. Biol. Med. 70:1949;617-622.
20. Koliatsos V.E., Price D.L. Axotomy as an experimental model of neuronal injury and cell death. Brain Pathol. 6:1996;447-465.
21. Koski C.L., Vanguri P., Shin M.L. Activation of the alternative pathway of complement by human peripheral nerve myelin. J. Immunol. 134:1985;1810-1814.
22. Koski C.L., Sanders M.E., Swoveland P.T., Lawley T.J., Shin M.L., Frank M.M., Joiner K.A. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies. J. Clin. Invest. 80:1987;1492-1497.
23. Lachmann, P.J., Peters, D.K., 1982. Complement. In: Lachmann, P.J., Peters, D.K. (Eds.), Clinical Aspects of Immunology, 4th edn. Blackwell Scientific Publications, Oxford, pp. 18-49.
24. Lennon V.A., Seybold M.E., Lindstrom J.M., Cochrane C., Ulevitch R. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J. Exp. Med. 147:1978;973-983.
25. McKinzie S., Tyce G.M., Brimijoin S. Lowered norepinephrine turnover as a sign of impaired ganglionic transmission after preganglionic lesioning by acetylcholinesterase antibodies. J. Pharmacol. Exp. Ther. 277:1996;817-822.
26. Miller S.M., Ermilov L.G., Szurszewski J.H., Hammond P., Brimijoin S. Differential disruption of neurotransmission by acetylcholinesterase antibodies in pre- and paravertebral sympathetic ganglia examined with intracellular microelectrodes. J. Auton. Nerv. Syst. 67:1997;156-167.
27. Mollnes T.E., Vandvick B., Lea T., Vartdal F. Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complex. J. Neurol. Sci. 78:1987;17-28.
28. Morgan B.P. Complement regulatory molecules: application to therapy and transplantation. Immunol. Today. 16:1995;257-259.
29. Piddlesden S.J., Jiang S., Levin J.L., Vincent A., Morgan B.P. Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis. J. Neuroimmunol. 71:1996;173-177.
30. Polinsky, R., 1993. Neurochemical and pharmacological abnormalities in chronic autonomic failure syndromes. In: Low, P. (Ed.), Clinical Autonomic Disorders. Little Brown, Boston, pp. 537-549.
31. Rakonczay Z., Brimijoin S. Monoclonal antibodies to rat brain acetylcholinesterase: Comparative affinity for soluble and membrane-associated enzyme and for enzyme from different vertebrate species. J. Neurochem. 46:1986;280-287.
32. Reichert F., Levitzky R., Rotshenker S. Interleukin 6 in intact and injured mouse peripheral nerves. Eur. J. Neurosci. 8:1996;530-535.
33. Rushmere N.K., Harrison R.A., van den Berg C.W., Morgan B.P. Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site. Biochem. J. 304:1994;595-601.
34. Rushmere N.K., Tomlinson S., Morgan B.P. Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function. Immunology. 90:1997;640-646.
35. Sawant-Mane S., Piddlesden S.J., Morgan B.P., Holers V.M., Koski C.L. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells. J. Neuroimmunol. 69:1996;63-71.
36. Schober A., Wolf N., Huber K., Hertel R., Krieglstein K., Minichiello L., Kahane N., Widenfalk J., Kalcheim C., Olson L., Klein R., Lewin G.R., Unsicker K. TrkB and neurotrophin-4 are important for development and maintenance of sympathetic preganglionic neurons innervating the adrenal medulla. J. Neurosci. 18:1998;7272-7284.
37. Vernino S., Adamski J., Kryzer T.J., Fealey R.D., Lennon V.A. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology. 50:1998;1806-1813.
38. Yu J., Dong S., Rushmere N.K., Morgan B.P., Abagyan R., Tomlinson S. Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity. Biochemistry. 36:1997;9423-9428.